8 Ankylosing Spondylitis Clinical Trials in Mobile, AL (2026)

Q: How do I join a clinical trial in Mobile?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Mobile research site will contact you.

Recruiting Ankylosing Spondylitis Studies in Mobile

NCT07000357Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

The purpose of this phase 3, randomized, placebo controlled, event-driven study is to assess the effect of AZD0780, an oral PCSK9 inhibitor, compared with placebo in reducing the risk of MACE-PLUS in ...

Mobile, ALPHASE315,100 participantsAstraZeneca

View Study Details

NCT07037433Recruiting

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morb...

Mobile, ALPHASE312,800 participantsAmgen

View Study Details

NCT07136012Recruiting

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization...

Mobile, ALPHASE311,000 participantsAmgen

View Study Details

NCT07431281Recruiting

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

The purpose of this study is to evaluate the efficacy and safety of sonesitatug vedotin in combination with capecitabine with or without rilvegostomig in first-line (1L) Claudin18.2 (CLDN18.2)-positiv...

Mobile, ALPHASE32,130 participantsAstraZeneca

View Study Details

NCT06977581Recruiting

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition t...

Mobile, ALPHASE2252 participantsPfizer

View Study Details

NCT07039916Recruiting

Study to Access the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

This is a 26-week study to assess the efficacy, safety and tolerability of IMVT-1402 in adult participants with mild to severe generalized myasthenia gravis....

Mobile, ALPHASE3231 participantsImmunovant Sciences GmbH

View Study Details

NCT05705531Recruiting

A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma

This study assesses how blood cell growth patterns (clonal hematopoiesis) relate to heart health or cardiovascular disease (CVD) after treatment in patients with Hodgkin lymphoma. In some patients, ca...

Mobile, AL190 participantsChildren's Oncology Group

View Study Details

NCT06467695Recruiting

Low Voltage Electrical Stimulation for Depression in Parkinson's Patients

The goal of this clinical trial is to determine the relative efficacy of fMRI model guided Transcranial Direct Current Stimulation (mgTDCS) in improving the depressive symptoms of patients with Parkin...

Mobile, ALNA40 participantsUniversity of South Alabama

View Study Details

About Ankylosing Spondylitis Clinical Trials in Mobile

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 8 ankylosing spondylitis clinical trials recruiting participants in Mobile, AL. These studies are seeking a combined 41,743 participants. Research is being sponsored by AstraZeneca, Amgen, Pfizer and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Mobile — FAQ

Are there ankylosing spondylitis clinical trials in Mobile?

Yes, there are 8 ankylosing spondylitis clinical trials currently recruiting in Mobile, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Mobile?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mobile research site will contact you about next steps.

Are clinical trials in Mobile free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mobile studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 8 active trials in Mobile are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated October 12, 2026 from ClinicalTrials.gov